ES2281516T3 - Inhibidores de la cruzipaina y otras cisteinas proteasas. - Google Patents

Inhibidores de la cruzipaina y otras cisteinas proteasas. Download PDF

Info

Publication number
ES2281516T3
ES2281516T3 ES02732145T ES02732145T ES2281516T3 ES 2281516 T3 ES2281516 T3 ES 2281516T3 ES 02732145 T ES02732145 T ES 02732145T ES 02732145 T ES02732145 T ES 02732145T ES 2281516 T3 ES2281516 T3 ES 2281516T3
Authority
ES
Spain
Prior art keywords
oxo
hexahydrofuro
pyrrol
alkyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02732145T
Other languages
English (en)
Spanish (es)
Inventor
Martin c/o Amura Therapeutics Limited QUIBELL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amura Therapeutics Ltd
Original Assignee
Amura Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0101179A external-priority patent/GB0101179D0/en
Application filed by Amura Therapeutics Ltd filed Critical Amura Therapeutics Ltd
Application granted granted Critical
Publication of ES2281516T3 publication Critical patent/ES2281516T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES02732145T 2001-01-17 2002-01-17 Inhibidores de la cruzipaina y otras cisteinas proteasas. Expired - Lifetime ES2281516T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0101179 2001-01-17
GB0101179A GB0101179D0 (en) 2001-01-17 2001-01-17 Biologically active compounds
US27535901P 2001-03-13 2001-03-13
US275359P 2001-03-13

Publications (1)

Publication Number Publication Date
ES2281516T3 true ES2281516T3 (es) 2007-10-01

Family

ID=26245571

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02732145T Expired - Lifetime ES2281516T3 (es) 2001-01-17 2002-01-17 Inhibidores de la cruzipaina y otras cisteinas proteasas.

Country Status (20)

Country Link
US (2) US7425562B2 (https=)
EP (1) EP1362052B1 (https=)
JP (1) JP4608183B2 (https=)
KR (1) KR100860067B1 (https=)
CN (1) CN1269822C (https=)
AT (1) ATE356130T1 (https=)
AU (1) AU2002219397B2 (https=)
BR (1) BR0206501A (https=)
CA (1) CA2436462C (https=)
CY (1) CY1106640T1 (https=)
DE (1) DE60218633T2 (https=)
DK (1) DK1362052T3 (https=)
ES (1) ES2281516T3 (https=)
IL (2) IL156774A0 (https=)
MX (1) MXPA03006224A (https=)
NO (1) NO328208B1 (https=)
NZ (1) NZ526913A (https=)
PT (1) PT1362052E (https=)
RU (1) RU2329266C2 (https=)
WO (1) WO2002057270A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
JP2004523506A (ja) 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物
EP1436255A1 (en) 2001-09-14 2004-07-14 Aventis Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
YU34604A (sh) 2001-11-14 2006-08-17 Aventis Pharmaceuticals Inc. Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže
DE60326473D1 (en) * 2002-07-16 2009-04-16 Amura Therapeutics Ltd Pyrrolderivate als hemmstoffe von cystein proteasen
US7399765B2 (en) * 2003-09-19 2008-07-15 Abbott Laboratories Substituted diazabicycloalkane derivatives
SE0400022D0 (sv) * 2004-01-08 2004-01-08 Medivir Ab New compounds
BRPI0506719A (pt) * 2004-01-08 2007-05-02 Medivir Ab composto, composição farmacêutica, e, uso de um composto
JP2005350417A (ja) * 2004-06-11 2005-12-22 Dai Ichi Seiyaku Co Ltd 還元的エーテル化法を用いたピロリジン誘導体の製造法
US7488848B2 (en) * 2005-03-21 2009-02-10 Virobay, Inc. Alpha ketoamide compounds as cysteine protease inhibitors
GB0513840D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0513839D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0614073D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614042D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614046D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614037D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614053D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614044D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614052D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
WO2008114054A1 (en) * 2007-03-19 2008-09-25 Medivir Ab Protease inhibitors
US7893067B2 (en) * 2007-06-27 2011-02-22 Medivir Ab Cysteine protease inhibitors
EP2719700A1 (en) 2008-01-09 2014-04-16 Amura Therapeutics Limited Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases
GB0804701D0 (en) 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
GB0804702D0 (en) * 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
US9409880B2 (en) 2011-01-20 2016-08-09 The Regents Of The University Of Colorado, A Body Corporate Modulators of TLR3/dsRNA complex and uses thereof
PT2891492T (pt) * 2012-08-30 2022-12-13 Univ Tokyo Agente de controlo de endoparasitas
CN106279188A (zh) * 2016-07-21 2017-01-04 青岛科技大学 一种多取代呋喃并[2,3‑b]吡咯衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652574A (en) * 1970-04-01 1972-03-28 Abbott Lab Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof
DE3601226A1 (de) * 1986-01-17 1987-07-23 Bayer Ag Dihydropyridinlactole, verfahren zur herstellung und ihre verwendung in arzneimitteln
RU2137768C1 (ru) * 1993-12-15 1999-09-20 Мерк энд Ко, Инк. Ингибиторы hiv протеазы
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
EP0923535A4 (en) 1996-08-28 2001-01-10 Smithkline Beecham Corp CYSTEINE PROTEASE INHIBITORS
EA002100B1 (ru) 1996-12-23 2001-12-24 Элан Фармасьютикалз, Инк. ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ
AR013079A1 (es) * 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
CO5150165A1 (es) 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
GB9911417D0 (en) * 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
JP2004513942A (ja) 2000-11-17 2004-05-13 メディヴァー　ユーケイ　リミテッド システインプロテアーゼインヒビター
JP2004523506A (ja) 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物

Also Published As

Publication number Publication date
CN1269822C (zh) 2006-08-16
JP2004518674A (ja) 2004-06-24
AU2002219397B2 (en) 2008-02-14
CA2436462A1 (en) 2002-07-25
EP1362052A1 (en) 2003-11-19
HK1060729A1 (en) 2004-08-20
BR0206501A (pt) 2004-01-13
RU2329266C2 (ru) 2008-07-20
CN1486320A (zh) 2004-03-31
NO20033220L (no) 2003-09-17
DK1362052T3 (da) 2007-07-09
WO2002057270A1 (en) 2002-07-25
US7425562B2 (en) 2008-09-16
EP1362052B1 (en) 2007-03-07
CA2436462C (en) 2011-07-05
IL156774A0 (en) 2004-02-08
MXPA03006224A (es) 2004-10-15
US20040138250A1 (en) 2004-07-15
CY1106640T1 (el) 2012-01-25
NZ526913A (en) 2004-12-24
KR100860067B1 (ko) 2008-09-24
NO328208B1 (no) 2010-01-11
JP4608183B2 (ja) 2011-01-05
IL156774A (en) 2008-08-07
NO20033220D0 (no) 2003-07-16
DE60218633D1 (de) 2007-04-19
ATE356130T1 (de) 2007-03-15
DE60218633T2 (de) 2008-02-21
KR20030075161A (ko) 2003-09-22
PT1362052E (pt) 2007-04-30
US20090247471A1 (en) 2009-10-01
RU2003125270A (ru) 2005-02-20

Similar Documents

Publication Publication Date Title
ES2281516T3 (es) Inhibidores de la cruzipaina y otras cisteinas proteasas.
AU2002219397A1 (en) Inhibitors of cruzipain and other cysteine proteases
US8877927B2 (en) Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors
JP2006504651A (ja) 生物活性化合物
JP2011509282A (ja) 化合物
BRPI0714722A2 (pt) tetraidrofuro[3,2-b]pirrol-3-onas como inibidores de catepsina k
US6958358B2 (en) Inhibitors of cruzipain and other cysteine proteases
US8053437B2 (en) Furo[3. 2-B] pyrrol derivatives
NZ526914A (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
US20040127424A1 (en) Inhibitors of cruzipain and other cysteine proteases
US20090131502A1 (en) Biologically active compounds
US7846934B2 (en) Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
US20040127549A1 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
BRPI0206501B1 (pt) An inhibitor compound of cruzipain and other cysteine ​​proteases, their uses, their pharmaceutical or veterinary composition, the process for the preparation of said composition and the method of establishing whether a cysteine ​​protease contributes to a biochemical function
AU2002225157A1 (en) Inhibitors of cruzipain and other cysteine proteases
AU2002219399A1 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
KR20050019877A (ko) 생물학적으로 활성이 있는 화합물